Label: GRAVOL- dimenhydrinate capsule, liquid filled

  • NDC Code(s): 10237-940-08, 10237-940-24
  • Packager: Church & Dwight Co., Inc.
  • Category: HUMAN OTC DRUG LABEL

Drug Label Information

Updated May 13, 2024

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active ingredient

    Dimenhydrinate 50 mg

  • Purpose

    antiemetic

  • Uses

    For the prevention and treatment of the nausea, vomiting and dizziness associated with motion sickness

  • Warnings

    Do not use for children under 6 years of age, unless directed by a doctor

    Ask a doctor before use if you or your child has

    • a breathing problem such as emphysema or chronic bronchitis
    • glaucoma
    • difficulty in urination due to enlargement of the prostate gland

    Ask a doctor before use if you or your child is taking a sedative or tranquilizer

    When using this product

    • may cause marked drowsiness
    • avoid alcoholic beverages
    • alcohol, sedatives and tranquilizers may increase the drowsiness effect
    • use caution when driving a motor vehicle or operating machinery

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children.

    In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) rtght away.

  • Directions

    To prevent motion sickness, the first dose should be taken ½ to 1 hour betore starting activity

    • Adults and children 12 years of age and older: take 1 or 2 capsules every 4 to 6 hours. Do not exceed 8 capsules in 24 hours, or as directed by a doctor
    • Children 6 to under 12 years of age: take 1 capsule every 6 to 8 hours. Do not exceed 3 capsules in 24 hours, or as directed by a doctor
  • Other Information

    Store between 59° – 77°F

  • Inactive ingredients

    D&C red 33, gelatin, glycerin, polyethylene glycol 400, povidone, purified water, sorbitol sorbitan solution

  • Questions or comments?

    Call us at 1-888-334-5387 M-F 9am-5pm ET

  • PRINCIPAL DISPLAY PANEL - 50 mg Capsule Blister Pack Carton

    Gravol™
    MOTION SICKNESS
    Dimenhydrinate capsules 50 mg

    24
    LIQUID GELS
    (Liquid Filled
    Capsules)

    TASTE FREE
    EASY TO SWALLOW

    PRINCIPAL DISPLAY PANEL - 50 mg Capsule Blister Pack Carton
  • INGREDIENTS AND APPEARANCE
    GRAVOL 
    dimenhydrinate capsule, liquid filled
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10237-940
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DIMENHYDRINATE (UNII: JB937PER5C) (DIPHENHYDRAMINE - UNII:8GTS82S83M) DIMENHYDRINATE50 mg
    Inactive Ingredients
    Ingredient NameStrength
    GELATIN, UNSPECIFIED (UNII: 2G86QN327L)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
    WATER (UNII: 059QF0KO0R)  
    D&C RED NO. 33 (UNII: 9DBA0SBB0L)  
    SORBITOL (UNII: 506T60A25R)  
    SORBITAN (UNII: 6O92ICV9RU)  
    POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)  
    Product Characteristics
    ColorPINKScoreno score
    ShapeCAPSULESize15mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:10237-940-081 in 1 CARTON03/02/2022
    18 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:10237-940-243 in 1 CARTON05/15/2024
    28 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC MONOGRAPH DRUGM00903/02/2022
    Labeler - Church & Dwight Co., Inc. (001211952)
    Establishment
    NameAddressID/FEIBusiness Operations
    Church & Dwight Canada Corp253933600PACK(10237-940)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!